Literature DB >> 15532763

Serum procalcitonin as an early marker of neonatal sepsis.

Daynia E Ballot1, Olga Perovic, Jacky Galpin, Peter A Cooper.   

Abstract

BACKGROUND: It has recently been suggested that procalcitonin (PCT) is of value in the diagnosis of neonatal sepsis, with varying results. This study was to evaluate the role of PCT as a single early marker of neonatal sepsis.
SETTING: Neonatal Unit, Johannesburg Hospital, and Microbiology Laboratory, National Health Laboratory Service (NHLS), South Africa. SUBJECTS AND METHODS: Neonates undergoing evaluation for sepsis between April and August 2002 were eligible for inclusion. Patients were categorised into 'no infection', 'possible infection' and 'definite infection' on the basis of C-reactive protein (CRP), white cell count (WCC), platelet count and blood culture results. PCT was correlated with infection categories.
RESULTS: One hundred and eighty-three neonates were enrolled. One hundred and eighteen had no infection, 52 possible infection and 13 definite infection. PCT differed significantly among infection categories (p < 0.0001) and correlated significantly with CRP at presentation (correlation coefficient 0.404, p < 0.001) and CRP at 24 hours (correlation coefficient 0.343, p < 0.001). PCT predicted 89.5% of definite infection. Receiver operating characteristic (ROC) analysis for PCT to predict definite infection showed odds ratio (OR) 1.145 (95% confidence interval (CI): 1.05-1.25) with an area under the curve of 0.778. PCT had a negative predictive value of 0.95 (95% CI: 0.915-0.988) for definite infection.
CONCLUSIONS: Although PCT was significantly related to the category of infection, it is not sufficiently reliable to be the sole marker of neonatal sepsis. PCT would be useful as part of a full sepsis evaluation, but is relatively expensive. A negative PCT on presentation may rule out sepsis, but this needs to be evaluated further.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532763

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

Review 1.  Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.

Authors:  Evridiki K Vouloumanou; Eleni Plessa; Drosos E Karageorgopoulos; Elpis Mantadakis; Matthew E Falagas
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440

2.  Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates.

Authors:  Cheryl Anne Mackay; Daynia Elizabeth Ballot; Olga Perovic
Journal:  Pediatr Rep       Date:  2011-06-16

3.  Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin.

Authors:  José B López Sastre; David Pérez Solís; Vicente Roqués Serradilla; Belén Fernández Colomer; Gil D Coto Cotallo; Xavier Krauel Vidal; Eduardo Narbona López; Manuel García del Río; Manuel Sánchez Luna; Antonio Belaustegui Cueto; Manuel Moro Serrano; Alfonso Urbón Artero; Emilio Alvaro Iglesias; Angel Cotero Lavín; Eduardo Martínez Vilalta; Bartolomé Jiménez Cobos
Journal:  BMC Pediatr       Date:  2006-05-18       Impact factor: 2.125

4.  Serum procalcitonin as a diagnostic marker of neonatal sepsis.

Authors:  In Ho Park; Seung Hyun Lee; Seung Taek Yu; Yeon Kyun Oh
Journal:  Korean J Pediatr       Date:  2014-10-31

5.  Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics.

Authors:  Mahbuba Meem; Joyanta K Modak; Roman Mortuza; Mahboob Morshed; Mohammad Shahidul Islam; Samir K Saha
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

6.  Evaluation of diagnostic value of procalcitonin as a marker of neonatal bacterial infections.

Authors:  Alireza Monsef; Fatemeh Eghbalian
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.